1.Clinical Study on the Therapeutic Effect of Shen-Fu Injection on Gastrointestinal Dysfunction in Patients with Septic Shock
Ziqian YUAN ; Sen WANG ; Qiliang HOU
Journal of Medical Research 2025;54(5):124-128
Objective The study aimed to investigate the effect of Shen-Fu injection on the clinical efficacy and prognosis of gas-trointestinal dysfunction in patients with septic shock.Methods Patients diagnosed with septic shock in the Department of Critical Care Medicine of the First Hospital of Lanzhou University from September 2021 to April 2024 were enrolled and divided into the Shen-Fu group and the conventional treatment group according to the treatment plan.The propensity score matching(PSM)was used for 1∶1 matc-hing.Clinical data of patients in both groups at enrollment,the main gastrointestinal symptoms(vomiting,diarrhea,abdominal disten-sion,abnormal bowel sounds,gastric retention),blood lactic acid(Lac),interleukin(IL)-6,procalcitonin(PCT),white blood cell(WBC),neutrophil percentage(NEUT%),the ratio of lactic acid to creatinine(Lac/SCr)before and 5days after treatment,and the mortality rate 28days after discharge were recorded.Results Compared with conventional treatment group(35.06%),the total effective rate(66.23%)of gastrointestinal efficacy in Shen-Fu group 5days after treatment was significantly higher(x2=14.964,P<0.05).The levels of Lac,WBC and Lac/SCr in Shen-Fu group was higher than that in conventional treatment group(P<0.05).There was no significant difference in IL-6,PCT and NEUT%(P>0.05).Compared with pre-treatment,the levels of IL-6,Lac,Lac/SCr de-creased after 5days of treatment in Shen-Fu group(P<0.05),while there was no significant difference in PCT,WBC and NEUT%(P>0.05).There was no statistically significant difference in mortality rate between the two groups at 28 days after discharge(P>0.05).Conclusion Shen-Fu Injection can improve gastrointestinal dysfunction in patients with septic shock,alleviate gastrointestinal symptoms,suppress inflammatory responses,enhance gastrointestinal tissue perfusion,and can improve the short-term prognosis of pa-tients with septic shock to some extent.
2.Clinical Study on the Therapeutic Effect of Shen-Fu Injection on Gastrointestinal Dysfunction in Patients with Septic Shock
Ziqian YUAN ; Sen WANG ; Qiliang HOU
Journal of Medical Research 2025;54(5):124-128
Objective The study aimed to investigate the effect of Shen-Fu injection on the clinical efficacy and prognosis of gas-trointestinal dysfunction in patients with septic shock.Methods Patients diagnosed with septic shock in the Department of Critical Care Medicine of the First Hospital of Lanzhou University from September 2021 to April 2024 were enrolled and divided into the Shen-Fu group and the conventional treatment group according to the treatment plan.The propensity score matching(PSM)was used for 1∶1 matc-hing.Clinical data of patients in both groups at enrollment,the main gastrointestinal symptoms(vomiting,diarrhea,abdominal disten-sion,abnormal bowel sounds,gastric retention),blood lactic acid(Lac),interleukin(IL)-6,procalcitonin(PCT),white blood cell(WBC),neutrophil percentage(NEUT%),the ratio of lactic acid to creatinine(Lac/SCr)before and 5days after treatment,and the mortality rate 28days after discharge were recorded.Results Compared with conventional treatment group(35.06%),the total effective rate(66.23%)of gastrointestinal efficacy in Shen-Fu group 5days after treatment was significantly higher(x2=14.964,P<0.05).The levels of Lac,WBC and Lac/SCr in Shen-Fu group was higher than that in conventional treatment group(P<0.05).There was no significant difference in IL-6,PCT and NEUT%(P>0.05).Compared with pre-treatment,the levels of IL-6,Lac,Lac/SCr de-creased after 5days of treatment in Shen-Fu group(P<0.05),while there was no significant difference in PCT,WBC and NEUT%(P>0.05).There was no statistically significant difference in mortality rate between the two groups at 28 days after discharge(P>0.05).Conclusion Shen-Fu Injection can improve gastrointestinal dysfunction in patients with septic shock,alleviate gastrointestinal symptoms,suppress inflammatory responses,enhance gastrointestinal tissue perfusion,and can improve the short-term prognosis of pa-tients with septic shock to some extent.
3.Lactobacillus gasseri LA39 promotes hepatic primary bile acid biosynthesis and intestinal secondary bile acid biotransformation.
Jun HU ; Qiliang HOU ; Wenyong ZHENG ; Tao YANG ; Xianghua YAN
Journal of Zhejiang University. Science. B 2023;24(8):734-748
A growing body of evidence has linked the gut microbiota to liver metabolism. The manipulation of intestinal microflora has been considered as a promising avenue to promote liver health. However, the effects of Lactobacillus gasseri LA39, a potential probiotic, on liver metabolism remain unclear. Accumulating studies have investigated the proteomic profile for mining the host biological events affected by microbes, and used the germ-free (GF) mouse model to evaluate host-microbe interaction. Here, we explored the effects of L. gasseri LA39 gavage on the protein expression profiles of the liver of GF mice. Our results showed that a total of 128 proteins were upregulated, whereas a total of 123 proteins were downregulated by treatment with L. gasseri LA39. Further bioinformatics analyses suggested that the primary bile acid (BA) biosynthesis pathway in the liver was activated by L. gasseri LA39. Three differentially expressed proteins (cytochrome P450 family 27 subfamily A member 1 (CYP27A1), cytochrome P450 family 7 subfamily B member 1 (CYP7B1), and cytochrome P450 family 8 subfamily B member 1 (CYP8B1)) involved in the primary BA biosynthesis pathway were further validated by western blot assay. In addition, targeted metabolomic analyses demonstrated that serum and fecal β-muricholic acid (a primary BA), dehydrolithocholic acid (a secondary BA), and glycolithocholic acid-3-sulfate (a secondary BA) were significantly increased by L. gasseri LA39. Thus, our data revealed that L. gasseri LA39 activates the hepatic primary BA biosynthesis and promotes the intestinal secondary BA biotransformation. Based on these findings, we suggest that L. gasseri LA39 confers an important function in the gut‒liver axis through regulating BA metabolism.
Mice
;
Animals
;
Bile Acids and Salts/metabolism*
;
Lactobacillus gasseri
;
Proteomics
;
Liver/metabolism*
;
Biotransformation
4.Study on the mechanism of genistein inhibiting the progression and metastasis of prostate cancer
Wenzhan LIU ; Qiliang CAI ; Baojun WU ; Siwei YANG ; Zhili YAO ; Zekai HOU ; Binxu SUN
Tianjin Medical Journal 2023;51(12):1288-1292
Objective To investigate the effect of genistein on the proliferation,migration and invasion of prostate cancer cells and its molecular mechanism.Methods Prostate cancer LNCaP and CWR22RV1 cells were divided into the control group(conventional culture)and the experimental group(50μmol/L genistein treatment).The effect of genistein on the proliferation of prostate cancer cells were analyzed by MTT assay.The effect of genistein on the migration and invasion of prostate cancer cells were analyzed by cell scratch assay and Transwell assay.The protein levels of epithelial interstital transformation(EMT)intermediate markers E-Cadherin,N-Cadherin,Vimentin,and tumor stem cell markers CD44 and Oct-4 were detected by Western blot assay.Results MTT assay showed that genistein could inhibit the proliferation of prostate cancer cells.The scratch closure rates of LNCaP and CWR22RV1 cells were significantly reduced in the experimental group compared with those in the control group,and the number of cells passing through the Transwell membrane was significantly reduced(P<0.05).Western blot assay showed that genistein could down-regulate the expression levels of N-Cadherin,Vimentin,CD44 and Oct4 in prostate cancer cells,and up-regulate the expression of E-Cadherin in epithelial cells(P<0.01).Conclusion Genistein reduces the dryness of prostate cancer cells by inhibiting the EMT process,thus reducing the proliferation,migration and invasion of prostate cancer cells.
5.Effects of intensive insulin therapy on the intestinal permeability in sepsis patients
Bin SHI ; Hong GUO ; Bin ZHANG ; Chao YIN ; Qiliang HOU ; Yongqiang CAO ; Xinzhong WEN
Parenteral & Enteral Nutrition 2010;17(1):11-12,16
Objective: To discuss the effect of intensive insulin therapy on D-lactic acid and diamine oxidase level in patients with sepsis.Methods: 48 patients was divided into control group and conventional group randomly.Content of D-lactic acid and diamine oxidase in serum was detected with absorption spectrometry before and after therapy.Result: D-lactic acid and diamine oxidase in patients decreased significantly in control group compared to that of conventional group.Conclusion: Insulin can depress interstinal permeability and ameliorate sepsis symptom resulted from bacterial translocation from intestine.
6.Effects of intensive controlled training of scapula for the pain of shoulder in patients with hemiplegia
Chinese Journal of Rehabilitation Medicine 2001;16(1):37-39
Objective: To discuss the effects of prevention and treatment of intensive controlled training of scapula for the pain of shoulder in patients with hemiplegia. Method:65 stroke patients werer randomly divided into treatment group (35 cases) and control group( 30 cases). All of them received routine rehabilitation. The treatment group was intensive trained on scapula control. Result: In the treatment group the pain of shoulder and function of upper- limbs were signficantly improved,as compare with control group. Conclusion:It's indicated that the intensive controlled training of scapula was effective for prevention and care of the pain of shoulder in hemiplegia.

Result Analysis
Print
Save
E-mail